Therapeutic strategy for pancreatic neuroendocrine tumours: An overview of the TNE West Network (2016-2024)

#4469

Introduction: Neuroendocrine tumours (NETs) are relatively rare and often diagnosed at an advanced stage, typically occurring between the ages of 40 and 60. They primarily manifest in the gastrointestinal system, pancreas, bronchi, lungs, thymus, and thyroid.

Aim(s): The main objective of this study is to analyse the therapeutic, epidemiological, and prognostic characteristics of pancreatic NETs within our department.

Materials and methods: We conducted a retrospective study within the TNE West Network, involving 90 cases observed between 2015 and 2024.

Conference:

Presenting Author: Bengueddach A

Authors: Bengueddache A, Kehili H, Tidjane A, Tabeti B, Manouni C,

Keywords: neuroendocrine tumour, metastasis, somatostatin analogue, pancreas,